I believe you're overthinking the negatives. Mifid does not directly impact STJ as they contract fund management out. Their transaction fees are already transparent and until noises-off become fact, comply with existing regulation. As you say, …
St. Jude will visit the Nasdaq MarketSite in Times Square along with Kmart, a mass merchandising company and …
The ticker and trading information for St. Jude Medical is displayed where the stock is traded on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., April 28, 2016. REUTERS/Brendan McDermid/File Photo NEW …
Andrew Croft, Chief Executive, commented: "After a record year for new business in 2017, we have maintained momentum in the first quarter of 2018. Gross inflows of £3.91 billion in the quarter were 21% higher than the prior year, while net …
St. Jude Medical stock went into a brief free-fall Thursday morning following publication of a short seller’s research report that lambasted the company for lax cybersecurity practices and predicted nearly half the med-tech company’s revenue …
Trading in the stock of medical device manufacturer St. Jude Medical was halted Friday afternoon after a dramatic drop in its value. That drop was triggered by news of alleged vulnerabilities in the company's cardiac care devices. The …
St. Jude's Valuation Story: Growth Drivers and Future Trends Stock performance St. Jude Medical (STJ) is an innovation-driven company with a leading position in the heart failure device market. It has a comprehensive and diversified portfolio …
STJ stock tumbled 5% on Thursday following reports that research firm Muddy Waters’ Carson Block cautioned the company’s medical devices have a major security flaw. Specifically, Block warned that St. Jude Medical’s …
(Reuters) - The stock of pacemaker manufacturer St. Jude Medical Inc STJ.N fell sharply on Thursday after short-selling firm Muddy Waters said it had placed a bet that the shares would fall, claiming its implanted heart devices were …
Medical device major St. Jude Medical, Inc. STJ recently announced the U.S. FDA ... much higher than the S&P 500’s 5.72% over the same time frame. The stock’s four-quarter average earning surprise is 41.67%. Quidel gained 19.34% in …